HYPERURICEMIA and GOUT PATHOGENESIS. HYPERURICEMIA Plasma/serum urate concentration >408 mol/L (6.8 mg/dL) Present in between 2.0 and 13.2% of ambulatory.

Slides:



Advertisements
Similar presentations
GOUT Disease caused by tissue deposition of Monosodium urate crystals as a result of supersatuaration of extra cellular fluid with MSU.
Advertisements

1. Describe the pathogenesis of hyperuricemia and gout Goup C1 Group C1.
1 CLINICAL CHEMISTRY (MLT 301) NONPROTEIN NITROGEN (NPN) LECTURE TWO Dr. Essam H. Jiffri.
Non-protein Nitrogen (NBN) 285 PHL. Non-protein Nitrogen Major components of the NPN Urea, uric acid, creatinine, creatine, amino acids & ammonia Importance:
Purine degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
Functions of nucleotides in biochemistry ● Building blocks of nucleic acids ● Cosubstrates and coenzymes ● Signaling.
Lesch-Nyhan Syndrome (LNS) By: Amir Sadafi and Bela Mohapatra.
Purine Degradation & Gout (Musculoskeletal Block)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.
Nucleic acids metabolism
Uric Acid and Hypertension
Gout.
 Gout is characterized by elevated uric acid concentrations in blood and urine due to variety of metabolic abnormalities that include overproduction.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Purine degradation & Gout (Musculoskeletal Block).
Gout Dr. Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
Uric acid estimation in plasma. Learning Objectives Describe the principle of uric acid estimation in serum and its clinical importance.
Uric acid xiaoli.
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
Purine Degradation & Gout (Musculoskeletal Block)
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Gout By Shravya & Helen. Gout is… An inflammatory arthritis associated with hyperuricaemia and intra-articular sodium urate crystals.
Uric Acid Metabolism & Gout
Metabolism of purine nucleotides A- De Novo synthesis: of AMP and GMP Sources of the atoms in purine ring: N1: derived from NH2 group of aspartate C2 and.
Purine degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
Stone Varieties Adalyn Almora. Terms Nephrolithiasis- (kidney stones) is a disease affecting the urinary tract. Nephrocalcinosis-Calcifications within.
Clinical Case #6 By Chen, chun-Yu (Kim) Chen, I -chun (Afra) Chen, I -chun (Afra)
Four Stages of Gout  Asymptomatic hyperuricemia Elevated levels of uric acid in the blood but no other symptoms Does not require treatment  Acute gout/Acute.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
GOUT. Demographics Affects middle-aged to elderly men postmenopausal and elderly women (usually have OA and HPN causing mild renal insufficiency, and.
Agents Used to Treat Hyperuricemia and Gout
GOUT A metabolic disease in which tissue deposition of crystals of monosodium urate occurs from supersaturated extracellular fluids and results in one.
GOUT: DIAGNOSIS AND MANAGEMENT. Gout Metabolic disorder due to excessive accumulation of uric acid in tissues leading to acute and chronic arthritis and.
Drug Therapy of Gout. Drug therapy of gout What Is Gout?
Metabolism of purine nucleotides
Gout. The most common cause of inflammatory arthritis in US adults (3.9% of Americans; approx. 8.3 million people; ) Prevalence is greater in.
Metabolic Diseases of the Bone
Metabolism of purine nucleotides A- De Novo synthesis: of AMP and GMP Sources of the atoms in purine ring: N1: derived from NH2 group of aspartate C2 and.
Dr. Müge Bıçakçıgil Kalaycı
Salvage Pathway of Purines. Purines that result from the normal turnover of cellular nucleic acids, or that are obtained from the diet and not degraded,
StagesClinical Features (1)Asymptomatic hyperuricemiahigh uric acid level is present but without symptoms (2) Acute Gouty Arthritishigh uric acid level.
Blood Urea Nitrogen (BUN) T.A. Bahiya Osrah. Introduction Many factors can affect on kidney function leads to kidneys damage. –Diabetes –high blood pressure.
Gout is a species-wide inborn error of purine metabolism D. Branch Moody, M.D. Professor of Medicine Immunology Laboratory, Smith Building
Lab (4): Renal Function test (RFT) Lecturer Nouf Alshareef KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2012
Lab (4): Renal Function test (RFT) Lecturers: Nouf Alshareef and Bahiya Osrah KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab.
Lab (4): Renal Function test (RFT)
Lab (4): Renal Function test (RFT) T.A Nouf Alshareef and T.A. Bahiya Osrah KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc.
Creatinine Creatinine is the waste product formed in muscle from a high energy storage compound ,creatine phosphate (phosphocreatine). ATP is the immediate.
Uric acid nephropathy 신장내과 R4 최선영. Endogenous production of uric acid Purine catabolism hypoxanthine xanthine Uric acid allantoin XO UO allopurinol -
Purine Degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
Metabolism of purine nucleotides A- De Novo synthesis: of AMP and GMP Sources of the atoms in purine ring: N1: derived from NH2 group of aspartate C2 and.
Purine degradation and Gout
Purine Degradation & Gout (Musculoskeletal Block)
URIC ACID Uric acid : Is the end product of purine metabolism. It is a wasteproduct derived from purines of the diet and those synthesized in the body.
Kidney Stones Renal Block 1 Lecture.
Gout.
Uric Acid Presented By Assist.Lecturer Aseel Ghassan Daoud
History Salient Features Physical Exam
Pathology for year 2, unit 3
GOUTY ARHTRITIS.
Drug Therapy of Gout 1.
  URIC ACID Muthana A. Al-Shemeri.
Antiuricaemic drugs Dr A.W Olusanya.
Measurement of Serum Uric Acid Illustration for Practical lessons; 2 nd. Year medical students, Mosul Medical College, 2013 Dr. Amjad Hazim Abid Al-Naemi.
Uric acid test By 51 Fifth Stage Student Sakar Karem Abdulla
 The word ‘gout’ is derived from the Latin word ‘gutta’.  Earlier it was believed that an acute attack of the disease was the result of poison dropping.
Purine Degradation & Gout (Musculoskeletal Block)
Purine Degradation & Gout (Musculoskeletal Block)
Presentation transcript:

HYPERURICEMIA and GOUT PATHOGENESIS

HYPERURICEMIA Plasma/serum urate concentration >408 mol/L (6.8 mg/dL) Present in between 2.0 and 13.2% of ambulatory adults, and is more frequent in hospitalized individuals Can result from increased production of uric acid decreased excretion of uric acid combination of the two processes Harrison’s Principles of Internal Medicine, 17 th edition

Pathophysiology occur because of decreased excretion (underexcretors), increased production (overproducers), or a combination of these two mechanisms. Underexcretion accounts for most causes of hyperuricemia

Hyperuricemia may be either exogenous (diet rich in purines) or endogenous (increased purine nucleotide breakdown) enzymatic defects – complete deficiency of hypoxanthine guanine phosphoribosyltransferase (HGPRT) – partial deficiency of HGPRT – increased production of 5-phospho-alpha-d- ribosyl pyrophosphate (PRPP) activity

Decreased Excretion of Uric Acid Gouty individuals excrete ~40% less uric acid than nongouty individuals May result from decreased glomerular filtration decreased tubular secretion enhanced tubular reabsorption Alcohol consumption Harrison’s Principles of Internal Medicine, 17 th edition

Decreased Glomerular Filtration Does not appear to cause primary hyperuricemia, but contributes to the hyperuricemia of renal insufficiency Uric acid excretion per unit of glomerular filtration rate increases progressively with chronic renal insufficiency Harrison’s Principles of Internal Medicine, 17 th edition

Decreased Tubular Secretion Tends to be preserved with chronic renal insufficiency Harrison’s Principles of Internal Medicine, 17 th edition

Enhanced Tubular Reabsorption Mechanism of many agents Occurs from "priming" renal urate reabsorption through the Na-dependent loading of proximal tubular epithelial cells with anions capable of trans-stimulating urate reabsorption A transporter in the brush border of the proximal tubular cells mediates Na-dependent resorption of components recognized to cause hyperuricemia by renal mechanisms Harrison’s Principles of Internal Medicine, 17 th edition

Enhanced Tubular Reabsorption Low doses of salicylates promote hyperuricemia through this mechanism Harrison’s Principles of Internal Medicine, 17 th edition

Alcohol Consumption Causes hyperuricemia by increasing urate production and decreasing uric acid excretion Accelerates hepatic breakdown of ATP to increase urate production Can also induce hyperlacticacidemia, which blocks uric acid secretion Higher purine content in some alcoholic beverages (beer) may also be a factor Harrison’s Principles of Internal Medicine, 17 th edition

GOUT Metabolic disease most often affecting middle- aged to elderly men and postmenopausal women Result of an increased body pool of urate with hyperuricemia Characterized by episodic acute and chronic arthritis, due to deposition of MSU crystals in joints and connective tissue tophi, and the risk for deposition in kidney interstitium or uric acid nephrolithiasis Harrison’s Principles of Internal Medicine, 17 th edition